SBC

In the past six months, SBC Medical Group Holdings, Inc. announced its 1Q 2026 financial results and its 2025 full-year earnings call. The company announced the rollout of its aesthetic healthcare-focused interpretation app and a secondary public offering of 3.1 million shares. A share repurchase program was announced, authorizing the repurchase of up to $5 million worth of shares. Insider selling activity by CEO Yoshiyuki Aikawa was reported. The stock price was $4.49 per share on April 17, 2026, compared to $4.11 per share on April 21, 2025, trading between $2.97 and $5.75 over the past 52 weeks. A flash report reiterated a "Buy-Extended" rating and a $9.00 price target.